T 0598/13 of 14.07.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T059813.20160714
- Date of decision
- 14 July 2016
- Case number
- T 0598/13
- Petition for review of
- -
- Application number
- 05380116.3
- IPC class
- A61K 51/08
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Therapeutic human albumin solutions with low prekallicrein activator (PKA) activity and process for obtaining them
- Applicant name
- Grifols, S.A.
- Opponent name
- CSL Behring GmbH
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 114Rules of procedure of the Boards of Appeal Art 12(1)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Keywords
- Evidence submitted in appeal proceedings
Evidence - admitted (yes)
Appeal decision - remittal to the department of first instance (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- T 1692/23
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the Opposition Division for further prosecution.